This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "2010-09-23 Call Agenda"

From HL7Wiki
Jump to navigation Jump to search
(New page: '''To return to the >> Oncology EHR Functional Profile or Agendas and Minutes''' ==HL7 Ambulatory Oncology Functional Profile Meeting== =...)
 
Line 24: Line 24:
 
#*  
 
#*  
 
# '''NCI Project Status Update ''' (Salimah)
 
# '''NCI Project Status Update ''' (Salimah)
−
#*  
+
#* Request to endorse the definition of "Agent" as follows:
 +
#** "''An agent is a distinct substance or ingredient (as defined by FDA’s prEN ISO/CD 11238) or compound/product/mixture thereof, contained in drugs, biologics, foods, and devices that act to produce a specific effect (commonly health related). This can include radiopharmaceutical, nutritional, complimentary and alternative medicine (CAM), molecular components of devices (i.e. silicon in implants) and nano-technologic agents but does not include whole devices, or procedures (i.e. surgeries). Individual agents included in a treatment regimen or therapy (i.e. Taxotere, Adriamycin and Cytoxan) are included in this definition, however, whole regimen names or other broad classification of therapies (i.e. “CHOP”, “chemotherapy”, etc), are not.''"
 +
#** RIM Definition is: "''Definition: a therapeutically active ingredient (player) in a mixture (scoper), where the mixture is typically a manufactured pharmaceutical. It is unknown if the quantity of such an ingredient is expressed precisely in terms of the playing ingredient substance, or, if it is specified in terms of a closely related substance (active moiety or reference substance).''".
 +
#*
 
# '''Overview Chpater - Clinical Review & Ballot Reconciliation'''
 
# '''Overview Chpater - Clinical Review & Ballot Reconciliation'''
 
#* Background ballot reconciliation files (for reference only) [[Media:EHR-S Ambulatory Oncology Functional Profile, R1.zip|Ballot Results ZIP file]] and [[Media:EHR_AOFP_R1_D1_2010MAY_2010510154819 All Submitted Comments.zip|Ballot Reconciliation Worksheet(ZIP)]]
 
#* Background ballot reconciliation files (for reference only) [[Media:EHR-S Ambulatory Oncology Functional Profile, R1.zip|Ballot Results ZIP file]] and [[Media:EHR_AOFP_R1_D1_2010MAY_2010510154819 All Submitted Comments.zip|Ballot Reconciliation Worksheet(ZIP)]]

Revision as of 00:04, 23 September 2010

To return to the >> Oncology EHR Functional Profile or Agendas and Minutes

HL7 Ambulatory Oncology Functional Profile Meeting

Meeting Logistics

Date/Time: Thursday, September 23rd, 2010 / 1:00 PM – 2:30 PM EST
Location: Phone: 1- 770-657-9270; Passcode: 510269
DIAL IN LOGISTICS:
https://www.livemeeting.com/cc/cdc/join?id=K7HXG6&role=attend&pw=t%24%23T%40%7D%7D8R
https://www.livemeeting.com/cc/cdc/join Meeting ID: K7HXG6 Participant Entry Code: t$#T@}}8R

Agenda

  1. Welcome and Introductions
  2. Agenda review and approval
  3. Approval of minutes from previous calls: September 9th
  4. Review Actions from previous meeting(s)
    1. Helen to contact Lori Havener (NAACCR) and Kenneth Gerlach (CDC) regarding ballot questions
  5. CCHIT Liaison Report (Peter)
  6. CDC NPCR Project Status Update (Sandy)
  7. NCI Project Status Update (Salimah)
    • Request to endorse the definition of "Agent" as follows:
      • "An agent is a distinct substance or ingredient (as defined by FDA’s prEN ISO/CD 11238) or compound/product/mixture thereof, contained in drugs, biologics, foods, and devices that act to produce a specific effect (commonly health related). This can include radiopharmaceutical, nutritional, complimentary and alternative medicine (CAM), molecular components of devices (i.e. silicon in implants) and nano-technologic agents but does not include whole devices, or procedures (i.e. surgeries). Individual agents included in a treatment regimen or therapy (i.e. Taxotere, Adriamycin and Cytoxan) are included in this definition, however, whole regimen names or other broad classification of therapies (i.e. “CHOP”, “chemotherapy”, etc), are not."
      • RIM Definition is: "Definition: a therapeutically active ingredient (player) in a mixture (scoper), where the mixture is typically a manufactured pharmaceutical. It is unknown if the quantity of such an ingredient is expressed precisely in terms of the playing ingredient substance, or, if it is specified in terms of a closely related substance (active moiety or reference substance).".
  8. Overview Chpater - Clinical Review & Ballot Reconciliation
  9. Other business
  10. Agenda items for next meeting (tbd)
Retrieved from "https://wiki.hl7.org/w/index.php?title=2010-09-23_Call_Agenda&oldid=41129"